Differentially expressed miRNAs detected in the cerebrospinal fluid (CSF).

<p>Sample size for cerebrospinal fluid consisted of 62 AD, 57 PD and 65 control subjects. Results were filtered at adjusted p-value <0.05. The logarithmic base 2 fold change (FC) is relative to the first listed group for each comparison. Significant miRNAs were reported if their normalized base average is greater than 5 mapped reads and 0.7< FC(log2) or FC(log2) <−0.7. Superscript 1 indicates miRNAs that are differentially expressed in both patients with Alzheimer's disease and Parkinson's disease compared to control subjects. Superscript 2 indicates differentially expressed miRNAs in both CSF and SER biofluids for the corresponding analysis. Significant miRNAs with a superscript 3 are in low abundance, with normalized mean <10 mapped reads.